Response to CAR - T Cell Therapy Similar for Minority Patients

Progression - free and overall survival similar for minority, nonminority patients receiving CAR - T cell therapy for non - Hodgkin lymphoma
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pathology, Journal, Source Type: news